Recent Finacing
Recent Raise
Recombine offers carrier-screening tests for 180 recessive disorders, processing ~8,000 patient sets annually using Illumina sequencers, existing automated lab workflows, and proprietary computational analysis to model multigene risk interactions.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor